Jump to content

Lymphocyte expansion molecule

From Wikipedia, the free encyclopedia

Lymphocyte expansion molecule (LEXM) is a protein discovered in 2015, found to be involved in immune responses (in mice) to some cancers and viruses.[1][2] The protein was initially found to be responsible for an increased production of T cells in mice. The original paper has since been retracted upon recommendation of Imperial College's investigators due to concerns about duplication of data.[3] The protein may be relevant to humans and could be a target for drug discovery.[4][5]

Scientists at Imperial College are developing a gene therapy based on this protein.[1]

References

[edit]
  1. ^ a b Knapton, Sarah (16 April 2015). "Scientists find key to 'turbo-charging' immune system to kill all cancers". telegraph.co.uk. The Telegraph. Retrieved 8 September 2017.
  2. ^ Okoye at al. (April 2015). "The protein LEM promotes CD8+ T cell immunity through effects on mitochondrial respiration". Science. 348 (6238): 995–1001. doi:10.1126/science.aaa7516. hdl:10044/1/34339. PMID 25883318. (Retracted, see doi:10.1126/science.aal5242, PMID 27980177,  Retraction Watch. If this is an intentional citation to a retracted paper, please replace {{retracted|...}} with {{retracted|...|intentional=yes}}.)
  3. ^ Retraction. 2016
  4. ^ Previously Unknown Protein Boosts Immunity to Cancer and Viruses. 2015
  5. ^ 'Game-changing' new way to fight cancer discovered